These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 34909030)

  • 21. Life context of pharmacological academic performance enhancement among university students--a qualitative approach.
    Hildt E; Lieb K; Franke AG
    BMC Med Ethics; 2014 Mar; 15():23. PubMed ID: 24606831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement.
    Franke AG; Lieb K; Hildt E
    PLoS One; 2012; 7(6):e40047. PubMed ID: 22768218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuroenhancement].
    Gründer G; Bartsch T
    Nervenarzt; 2014 Dec; 85(12):1536-43. PubMed ID: 25403289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological Cognitive Enhancement: Current Situation and Perspectives].
    Yamamoto M
    Yakugaku Zasshi; 2022; 142(5):521-526. PubMed ID: 35491158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroenhancement: status quo and perspectives.
    Normann C; Berger M
    Eur Arch Psychiatry Clin Neurosci; 2008 Nov; 258 Suppl 5():110-4. PubMed ID: 18985306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroenhancement among German university students: motives, expectations, and relationship with psychoactive lifestyle drugs.
    Eickenhorst P; Vitzthum K; Klapp BF; Groneberg D; Mache S
    J Psychoactive Drugs; 2012; 44(5):418-27. PubMed ID: 23457893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smart drugs "as common as coffee": media hype about neuroenhancement.
    Partridge BJ; Bell SK; Lucke JC; Yeates S; Hall WD
    PLoS One; 2011; 6(11):e28416. PubMed ID: 22140584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. True and false concerns about neuroenhancement: a response to 'Neuroenhancers, addiction and research ethics', by D M Shaw.
    Heinz A; Kipke R; Müller S; Wiesing U
    J Med Ethics; 2014 Apr; 40(4):286-7. PubMed ID: 23468510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.
    Graf WD; Nagel SK; Epstein LG; Miller G; Nass R; Larriviere D
    Neurology; 2013 Mar; 80(13):1251-60. PubMed ID: 23486879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive neuroenhancement: false assumptions in the ethical debate.
    Heinz A; Kipke R; Heimann H; Wiesing U
    J Med Ethics; 2012 Jun; 38(6):372-5. PubMed ID: 22228818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students.
    Maier LJ; Haug S; Schaub MP
    Drug Alcohol Depend; 2015 Nov; 156():221-227. PubMed ID: 26455555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroenhancement strategies for psychiatric disorders: rationale, status quo and perspectives.
    Normann C; Nissen C; Frase L
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S113-6. PubMed ID: 22932721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroenhancement: wisdom of the masses or "false phronesis"?
    Larriviere D; Williams MA
    Clin Pharmacol Ther; 2010 Oct; 88(4):459-61. PubMed ID: 20856244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relevance of pharmacological neuroenhancement for stress and resilience-A multistudy report.
    Darwig J; Gaum PM; Pauli R; Nassri L; Lang J
    Front Public Health; 2022; 10():971308. PubMed ID: 36438304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use of Prescription Drugs, Recreational Drugs, and "Soft Enhancers" for Cognitive Enhancement among Swiss Secondary School Students.
    Liakoni E; Schaub MP; Maier LJ; Glauser GV; Liechti ME
    PLoS One; 2015; 10(10):e0141289. PubMed ID: 26505633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets.
    Dietz P; Iberl B; Schuett E; van Poppel M; Ulrich R; Sattler MC
    Front Pharmacol; 2018; 9():494. PubMed ID: 29946254
    [No Abstract]   [Full Text] [Related]  

  • 37. [Doping for the brain].
    Iglseder B
    Z Gerontol Geriatr; 2018 Feb; 51(2):143-148. PubMed ID: 29209802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Complexity of Neuroenhancement and the Adoption of a Social Cognitive Perspective.
    Zelli A; Lucidi F; Mallia L
    Front Psychol; 2015; 6():1880. PubMed ID: 26648906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What should we do about student use of cognitive enhancers? An analysis of current evidence.
    Ragan CI; Bard I; Singh I;
    Neuropharmacology; 2013 Jan; 64():588-95. PubMed ID: 22732441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review.
    Sharif S; Guirguis A; Fergus S; Schifano F
    Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33802176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.